Health Condition 1: N944- Primary dysmenorrhea
Conditions
Interventions
Intervention1: Homoeopathic Medicine: Oral route of administration pill form
30 number pill size
Centesimal scale
First dose after case taking and subsequent doses after each follow up
Potency acc
Sponsors
Bakson Homoeopathic Medical College And Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Participants with primary dysmenorrhea scoring more than 1 in WaLIDD score. Participants who are under the age group of 12 – 25 years of age. Participants with pain only during menstruation; with minimum of 3 cycles. Participants having poor sleep quality during menstrual cramp.
Exclusion criteria
Exclusion criteria: Participants who are suffering with any systemic or psychiatric or endocrine illness or under substance abuse or immunocompromised. Participants who are under any sort of treatment. Participants with known history of pathological pelvic conditions. Participants who refuse to give the consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the scores in WaLIDD be will improved at the end of treatment, highlighting the benefits of Lippe’s keynotes and red line symptoms of the Materia Medica Timepoint: WaLIDD scale will be evaluated at baseline, 12th week, 24th weeks 15 months study Enrolment period 6 months Follow ups 6 months Data analysis and report writing 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that the scores in PSQI be will improved at the end of treatment, highlighting the benefits of Lippe’s keynotes and red line symptoms of the Materia Medica. Timepoint: PSQI scale will be evaluated at baseline, 12th week, 24th week 15 months study Enrolment period 6 months Follow ups 6 months Data analysis and report writing 3 months | — |
Countries
India
Contacts
Public ContactDr Ashwini Nair
Bakson Homoeopathic Medical College and Hospital
Outcome results
None listed